
Review the appropriate monitoring for patients using hydroxocobalamin.
Describe the potential adverse effects of hydroxocobalamin. Identify the mechanism of action of hydroxocobalamin. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team) in the treatment of patients with vitamin B12 deficiency and related conditions. This activity outlines the indications, action, and contraindications for hydroxocobalamin as a valuable agent in managing macrocytic anemia and acute cyanide toxicity.
Hydroxocobalamin is a medication used in the management and treatment of vitamin B12 deficiency and acute cyanide toxicity.